Moreover, when the LTR patients were compared to other ulcerative colitis patients in remission with normalized mucosal TNF gene expression that experience a relapse within the first year after anti-TNF discontiuation, there is a significant difference in the pro inflammatory pathways including IL17 and IL 23. The gene discussed is TNF; the disease is ulcerative colitis.